 CAMPBELL, Calif., Nov. 13, 2020 GLOBE NEWSWIRE -- On November 10, 2020, VIVUS, Inc. the Company, a biopharmaceutical company, filed the Second Amended Joint Prepackaged Chapter 11 Plan of Reorganization of VIVUS, Inc. and Its Affiliated Debtors Docket No. 339 as may be amended, modified, or supplemented from time to time, the Plan with the United States Bankruptcy Court for the District of Delaware the Bankruptcy Court. As set forth in a letter filed with the Bankruptcy Court the Equity Support Letter, the Plan has the full support of the official committee of equity security holders appointed in the Companys chapter 11 case the Equity Committee and incorporates the terms and conditions of the plan support agreement filed with the Bankruptcy Court on November 5, 2020 Docket No. 329 and available, along with all other documents filed with the Bankruptcy Court, on the electronic case filing docket and free of charge on the website maintained by the Companys voting agent, Bankruptcy Management Solutions, Inc. dba Stretto the Voting Agent at This press release is qualified in its entirety by the Plan and the Plan Supplement as defined herein, which govern in the event of any inconsistency. Unless otherwise indicated, all capitalized terms used herein have the same meaning assigned in the Plan. 